Blood flow influences vascular growth during tumour angiogenesis by Nasu, R et al.
Many investigators have studied the histologic and morphologic
changes associated with the proliferation of new vessels and
tumour neovascularization by direct observation using transparent
chambers in rats (Yamaura et al, 1971; Hori et al, 1990, 1992,
1993a, 1993b; Folkman and Klagsbrun 1987; Helmlinger et al,
1997). Recent studies using this technique have revealed a rela-
tionship between the branching and formation of tumour vascular
networks and arterial blood pressure (Hori et al, 1990; Dewhirst
et al, 1992; Patan et al, 1996; Helmlinger et al, 1997). Neo-
vascularization of implanted tumours is rapid for the first 24 h
(Hori et al, 1992). Several studies have documented a relationship
between vascular growth factors like vascular endothelial growth
factor and the formation of a normal vascular network in the pres-
ence of ischaemia (Shweiki et al, 1992; Kondo et al, 1993; Gazit et
al, 1995; Nagy et al, 1995). The importance of blood flow to
neovascularization has long been recognized. Clark et al (1918)
noted that vessels with a high blood flow continued to grow,
whereas those with little or no blood flow underwent involution.
Even vessels adjacent to the area of high blood flow that measured
more than 10 mM in diameter underwent involution and were
resorbed if local blood flow was decreased or halted. This obser-
vation suggested that not only angiogenetic vascular growth
factors but also haemodynamic factors play an important role in
neovascularization. In the present study, we continuously observed
blood vessels in implanted tumours for 6 h under normal physio-
logical conditions using a dorsal flap transparent chamber and a
video camera to analyse the relationship between changes of blood
flow and tumour vessel diameter during neovascularization.
MATERIALS AND METHODS
Transparent chamber
Transparent quartz glass windows (1 mm thick and 1 cm in diam-
eter) with aluminium frames were constructed and applied to rats
as described previously (Yamaura et al, 1971).
Experimental animals and tumour implants
Female Fisher rats aged 7–8 weeks and weighing 130–150 g were
obtained from Shimizu Laboratory Animal Center (Shizuoka,
Japan) and were used in all experiments. A small piece (0.1 mm3) of
mammary carcinoma was implanted under the transparent chamber
of each rat. The tumour was rat mammary adenocarcinoma 13762, a
carcinogen (dimethylbenz [a] anthracene-induced tumour of female
Fisher-344 rat) (American Type Culture Collection Inc., Rocklawn,
MD, USA), which forms fold and acini of epithelial tissue and
grows to 100 mm3 in about 14 days (Kakeji et al, 1997). The tumour
was maintained by subcutaneous transplantation before use in the
study. Implanted tumour pieces were held in position using soft agar
(0.05%) to all on observation through the window. The subcuta-
neous tissue within the transparent chamber was 100 mM thick and
the implanted tumours formed sheets of cells in this space. We
selected one transparent chamber that was growing in a normal
physiological condition without inflammation and that was dry in
the chamber. The tumour was studied when a mean diameter of
6 mm was reached 25 days after transplantation into the transparent
chamber. The animals were kept in a sterile environment and
all experiments were performed according to Kansai Medical
University’s guidelines for animal handling.
Observation and photography
The rats with transparent chambers were anaesthetized using
intraperitoneal nembutal sodium (25 mg/kg) and fixed to a micro-
scope with a specially constructed jig. The body temperature was
Blood flow influences vascular growth during tumour
angiogenesis
R Nasu, H Kimura, K Akagi, T Murata and Y Tanaka
Department of Radiology, Kansai Medical University, 10–15, Fumizono-cho, Moriguchi-city, Osaka, 570, Japan
Summary Many factors play a role in tumour angiogenesis. We observed growing tumour vessels in vivo to study the relationship between
blood flow and vascular enlargement. Mammary adenocarcinoma was implanted into Fisher-344 rat with dorsal skin-fold transparent
chambers. Vascular growth was observed and recorded on videotape through a microscope for 6 h. Vascular networks were photographed and
traced every 30 min to identify changes over time. Tumour sections were stained with Masson’s trichrome and anti-Factor VIII-related antigen.
Tumour growth was rapid enough for differences to be seen each hour. Vessels with a high blood flow showed an increase in diameter within a
few hours and new branches formed from these vessels. In contrast, vessels without an increase in blood flow showed no change in diameter.
Vessels within the interstitium surrounding the tumour were lined by endothelium that was positive for anti-Factor VIII-related antigen staining.
Vessels in the tumour had extremely rare endothelial cells detectable by Masson’s trichrome or anti-Factor VIII-related antigen staining. In
conclusion, increased blood flow may cause vascular enlargement and some primitive vessels seem to lack endothelium.
Keywords: neovascularization; experimental tumour; transparent chamber
780
British Journal of Cancer (1999) 79(5/6), 780–786
© 1999 Cancer Research Campaign
Article no. bjoc.1998.0125
Received 3 December 1997
Revised 30 June 1998
Accepted 2 July 1998
Correspondence to: R NasuTumour neovascularization 781
British Journal of Cancer (1999) 79(5/6), 780–786 © Cancer Research Campaign 1999
2
5
0
 
m
M
2
5
0
 
m
M
0 min
120 min
2
5
0
 
m
M
2
5
0
 
m
M
240 min
360 min
Figure 1 Photomicrographs obtained every 2 h. The magnification of the objective lens was ´ 40 and the eyepiece was ´ 10. Vessel diameters were
measured with calipers on the photos
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maintained for 6 h using a heating pad while the tumours were
observed and tumour growth was recorded using a video camera
(Victor Japan, Tokyo, Japan) attached to the microscope
(Optiphoto-2, Nikon, Japan). Photomicrographs were obtained
every hour (magnification ´ 640). Our observations were done
under nembutal sodium anaesthesia, which can affect the blood
pressure and heart rate, but we observed the same rat for 6 h so we
could obtain stable data.
Measurement of changes in vessel diameter and blood
flow
Measurement of vessel diameter
The diameters of the seven vessels shown in Figure 1, ranging
from 7.14 to 16.07 mM, were measured with calipers on the
photomicrographs obtained every hour. Measurements were
corrected by the magnifying ratio to obtain the actual diameters.
Measurement of blood flow
Figure 2 shows a typical video image obtained at the start of the
observation period. The distance (points a–b) that an erythrocyte
travelled along the vessel in 0.1 s was measured with calipers and
corrected by the magnifying ratio to obtain the blood flow rate
(mM/0.1 s). To minimize errors, the blood flow rate was measured
10 times in the same vessel, and the mean value was calculated.
Changes in the diameter and blood flow of the seven vessels
were determined every hour for 6 h. The rate of change of each
parameter was calculated as a ratio by setting the value obtained at
the start of observation as 1.00. The seven tumour vessels were
assigned to groups showing an increase in diameter or no change
in diameter (expanding and non-expanding groups, respectively).
Only a few vessels could be used to measure the blood flow and
diameter over 6 h accurately, because many new branch vessels
formed and the direction of blood flow often changed during
angiogenesis. In addition, growth of the tumour tissue led to
decreasing visibility, so it was difficult to identify the same vessels
for 6 h. As a result, we could only measure the blood flow and
diameter of seven vessels.
Staining of tumour sections
After observing the blood vessels for 6 h, the rats were killed and
the tumours were removed and fixed in formalin. Tumour sections
250 mM
Figure 2 Video image obtained at the start of observation. The magnification of the objective was ´ 40 and that of the camera lens was ´ 16. Positions a (¯) to
b (¯) show the distance an erythrocyte moved in 0.1 s
Table 1 The changes of vessel diameter (mM)
Number of vessels
Expanding Non-expanding
Time (min) 1 2 3 4 5 6 7
0 8.93 10.71 7.14 16.07 7.14 7.14 7.14
60 8.93 17.86 13.40 22.33 8.93 7.14 7.14
120 10.71 13.40 16.70 10.71 8.93 7.14 4.47
180 8.93 17.86 8.93 10.71 7.14 7.14 7.14
240 13.40 13.40 8.93 10.71 8.93 6.25 4.47
300 17.86 17.86 10.71 10.71 8.93 7.14 4.47
360 13.40 13.40 16.07 8.93 8.93 7.14 4.47
Hourly changes of vascular diameters in the expanding (nos 1, 2 and 3) and
non-expanding (nos 4, 5, 6 and 7) groups.
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were cut and stained with Masson’s trichrome stain and a rabbit
antibody for Factor VIII-related antigen (Tanner, Kobe, Japan)
(Otsuki et al, 1990). Then histological examination was done at a
magnification of ´ 400 (Figure 3).
RESULTS
Table 1 shows changes of diameter over time in the two groups of
vessels. Vessels in the expanding group showed an increase in
vascular diameter over the 6 h of observation. Vessels in the non-
expanding group either contracted or did not change in size. The
mean rate of change was 1.67 for the expanding group and 0.97 for
the non-expanding group (Figure 4).
Table 2 shows the changes in blood flow rates over time for the
two groups. The blood flow rate increased in both groups, but the
change was more marked in the expanding group. The mean rate
of change at 6 h was 1.442 for the expanding group and 1.197 for
the non-expanding group (Figure 5).
Figures 3 and 6 show tumour growing in a transparent chamber.
Masson’s trichrome-stained sections revealed fibrous tissue adja-
cent to the vessels in the areas surrounding the tumour (Figure
3A), but little fibrous tissue adjacent to vessels of a similar diam-
eter within the tumour (Figure 3B). The anti-Factor VIII-related
antigen-stained sections showed a uniform distribution of endothe-
lial cell nuclei in the vessels within the interstitium surrounding
the tumour (Figure 6A), and a non-uniform distribution of
endothelial cell nuclei in the tumour vessels (Figure 6B). Vessels
in the tumour had extremely rare endothelial cells.
DISCUSSION
Although there are a few reports directly observing the growth of
tumours and the formation of tumour vessel networks (Ide et al,
1939; Algire, 1943), the effects of administering vasoactive
substances and angiogenesis inhibitors on neovascularization have
been studied in the past few years (Dewhirst et al, 1992; Hori et al,
1992, 1993a). Neovascularization of tumours has been assessed in
terms of arterial branching, the lengthening of blood vessels and
the effect of arterial blood pressure (Dewhirst, 1992; Hori et al,
1992, 1993a).
It has been suggested that tumour neovascularization is stimu-
lated by the death of tumour cells, because cells surrounding the
tissue release vascular growth factors. These angiogenetic factors
stimulate vascular endothelial cells to secrete proteolytic enzymes
including plasminogen activator and collagenase. These enzymes
break down the basement membrane to produce small defects in
the vessel wall, which endothelial cells can then cross to form new
vessels (Patan et al, 1996). Folkman and Klagsbrun (1987)
reported that endothelial cells become organized into tubular
structures (capillary loops) and form anastomoses between
A
B
50 mm
50 mm
Figure 3 Histology of tumours grown in rat dorsal flap transparent
chambers. (A) Masson’s trichrome stain demonstrates fibrous tissue adjacent
to the non-tumour vessels (¯). (B) There is little fibrous tissue adjacent to
vessels of similar diameter within the tumour (¯). Part of the tumour vessel
wall has no endothelial cells or fibrous tissue
Table 2 The changes of blood flow in expanding and non-expanding groups
(mM/0.1 s)
Number of vessels
Expanding Non-expanding
Time (min) 1 2 3 4 5 6 7
0 25.02 30.86 31.97 41.14 60.88 31.69 30.02
60 22.24 32.53 37.81 29.75 43.09 30.30 30.02
120 43.09 30.58 36.70 43.92 38.92 31.40 31.40
180 47.26 38.36 41.42 45.59 41.70 32.53 31.40
240 48.37 43.65 44.76 41.14 47.82 32.25 35.58
300 45.59 56.71 47.82 48.09 42.26 40.87 39.20
360 34.47 48.93 43.65 51.15 61.99 42.53 35.58784 R Nasu et al
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themselves and elements of the host vasculature during the estab-
lishment of a primitive tumour circulation. However, Baillie et al
(1995) have found that tissues with pre-existing blood vessels
formed tumour vascular networks by a process that differs from
Folkman’s model.
In the present experiment, we observed no sprouting of new
blood vessels. In all tumours, primitive blood flow of both red and
white blood cells was seen between individual tumour cells. Some
of the vessels with increasing flow rates became dedicated tumour
blood vessels, whereas others stopped growing depending on the
pressure gradient. In the latter case, primitive blood vessel flow
was small and eventually ceased.
Clark (1918) studied the normal vascular network in tadpole
tails and provided evidence supporting Thoma’s theory:
1. an increase or decrease in vessel size is regulated by the rate of
blood flow
2. an increase or decrease in vessel length is governed by the
tension exerted on the vessel wall in a longitudinal direction
by the surrounding tissues
3. an increase or decrease in vessel wall thickness is dependent
on blood pressure
4. formation of new capillaries depends upon the increase in
pressure of the capillary (Thoma, 1893; Wu et al, 1993).
Our present findings agree with those of Clark (1918).
Implantation of a tumour adjacent to a normal vessel (within
100 mM) led to tumour growth. Two types of vessels appeared to
form the tumour vascular network: some normal host vessels
became tumour vessels, and other tumour vessels grew de novo. It
is well known that microhaemodynamics of tumour vessels varies
at different locations in a tumour. We investigated vessels that
were growing rapidly at the periphery of the tumour. We had much
data about tumour neovascularization using the transparent
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Figure 4 The time-course of vessel diameter changes in the expanding and non-expanding groups
Figure 5 The time-course of mean blood flow rates in the two groups
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chamber. We did not analyse qualitative findings of other tumour
angiogenesis over 6 h, but observations showed the same
tendency. It was possible to analyse changes of only a few tumour
vessels. In the light microscopic field, we could find vessels that
showed increasing or decreasing blood flow and diameter. The
tumour vascular network appeared to form as follows.
First, primitive blood vessels that coursed through intercellular
sinusoids and between tumour cells were formed through which
only one or two red blood cells could pass abreast. These primitive
blood vessels might then form loop vessels (10–20 mM), with a
diameter large enough for three to five red blood cells to pass.
Such vessels showed only intermittent flow. If blood flow in such
a vessel became obstructed, the vessel disappeared. However, if
blood flow in the loop vessel increased, the loop became larger. An
increase in the number of loops subsequently led to an increase in
loop diameter. Histologic examination of these loop vessels did
not reveal endothelial cells. Finally, the loop vessels enlarged and
joined with adjacent vessels to form a new flow path. Loop vessels
with increasing blood flow showed an increase in diameter (35–
50 mM) and became tumour vessels. In many cases, the walls of
these tumour vessels were not uniformly lined by endothelium
(Figure 6). It has been reported that cells other than endothelial
cells are involved in forming the walls of tumour vessels (Baillie
et al, 1995). In our study, Masson’s trichrome-stained sections
revealed little fibrous tissue adjacent to blood vessels near the
interstitial vascular lumens that surrounded the tumour, and some
vessels had no lining of endothelial cells (Figure 3).
In conclusion, these findings suggest that the continued growth
of tumour blood vessels depends more on local haemodynamics
than on vascular growth factors.
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